Leydig tumor cell protein phosphorylated in response to stimulation with choriogonadotropin or epidermal growth factor is identified as stathmin

Endocrinology. 1994 Aug;135(2):662-6. doi: 10.1210/endo.135.2.8033814.

Abstract

Although hCG and mouse epidermal growth factor activate different signaling systems in a clonal strain of Leydig tumor cells (designated MA-10), both compounds are capable of increasing steroidogenesis, decreasing transcription of the LH/CG receptor gene, and attenuating adenylyl cyclase. We have recently identified a 21-kilodalton protein (p21) that is a potential intermediary in the actions of mouse epidermal growth factor and hCG. Characterization of p21 revealed similarities to stathmin, a ubiquitous phosphoprotein whose phosphorylation is associated with diverse second messenger pathways. Using two different experimental approaches, Western blotting and immunoprecipitation, we present data that identify p21 as stathmin.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Animals
  • Blotting, Western
  • Chorionic Gonadotropin / pharmacology*
  • Epidermal Growth Factor / pharmacology*
  • Immunosorbent Techniques
  • Leydig Cell Tumor / metabolism*
  • Male
  • Mice
  • Microtubule Proteins*
  • Phosphoproteins / metabolism*
  • Phosphorylation
  • Stathmin
  • Tumor Cells, Cultured

Substances

  • Chorionic Gonadotropin
  • Microtubule Proteins
  • Phosphoproteins
  • Stathmin
  • Stmn1 protein, mouse
  • 8-Bromo Cyclic Adenosine Monophosphate
  • Epidermal Growth Factor